225 related articles for article (PubMed ID: 807945)
1. Myocardial infarction in diabetics.
Soler NG; Bennett MA; Pentecost BL; Fitzgerald MG; Malins JM
Q J Med; 1975 Jan; 44(173):125-32. PubMed ID: 807945
[TBL] [Abstract][Full Text] [Related]
2. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
3. Survival after myocardial infarction in diabetic patients. Part II. Hospital mortality in relation to the kind of hypoglycaemic treatment.
Królewski AS; Janeczko D; Kobryń A; Puncewicz B
Acta Med Pol; 1975; 16(1):53-9. PubMed ID: 1119327
[No Abstract] [Full Text] [Related]
4. [Glibenclamide, a new oral antidiabetic].
Edlén A
Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
[No Abstract] [Full Text] [Related]
5. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a new oral drug in the treatment of diabetes mellitus].
Lubetzki J
Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
[No Abstract] [Full Text] [Related]
7. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
8. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
9. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents.
Mathew V; Frye RL; Lennon R; Barsness GW; Holmes DR
Am J Cardiol; 2004 Feb; 93(4):399-403. PubMed ID: 14969610
[TBL] [Abstract][Full Text] [Related]
10. The treatment of diabetes mellitus with oral hypoglycaemic drugs.
Duncan LJ; Clarke BF; Munro JF
Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054
[No Abstract] [Full Text] [Related]
11. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
Kadota I
Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
[No Abstract] [Full Text] [Related]
12. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance].
Torri A; Zanni A; Roncaia R; Di Saverio S
Clin Ter; 1977 Jul; 82(1):45-56. PubMed ID: 409583
[No Abstract] [Full Text] [Related]
13. [Diabetes mellitus under 30 years of age. Results of 18 years experience with oral treatment (author's transl)].
Mirouze J; Cartry E
Diabete Metab; 1975 Jun; 1(2):113-8. PubMed ID: 1234068
[TBL] [Abstract][Full Text] [Related]
14. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
15. Oral management of uncomplicated maturity onset diabetes.
Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
[No Abstract] [Full Text] [Related]
16. [Antidiabetic therapy in diabetic patients with coronary heart disease].
Faglia E
Minerva Med; 2003 Dec; 94(6):387-99. PubMed ID: 14976467
[TBL] [Abstract][Full Text] [Related]
17. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
Polosa P; Mughini L
Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
[No Abstract] [Full Text] [Related]
18. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
19. In-hospital outcome of acute myocardial infarction (st segment elevation type) in diabetics and non-diabetics.
Abid AR; Mallick NH; Shahbaz A; Tarin SA
J Coll Physicians Surg Pak; 2005 Sep; 15(9):524-7. PubMed ID: 16181568
[TBL] [Abstract][Full Text] [Related]
20. Treatment with glibenclamide in maturity-onset diabetes mellitus.
Persson I; Madsen SN
Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
